Evidence map›Paper›PMID 34548354›Full record

ArticleBMJ open2021

Cohort profile: a national, community-based prospective cohort study of SARS-CoV-2 pandemic outcomes in the USA-the CHASING COVID Cohort study.

McKaylee M Robertson, Sarah Gorrell Kulkarni, Madhura Rane, Shivani Kochhar, Amanda Berry, Mindy Chang, Chloe Mirzayi, William You, Andrew Maroko, Rebecca Zimba and 6 more

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06119854 (Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06119854 nacompletednot on this mapstarted 2024, after this paper: background citation

Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression

TypeinterventionalSponsorCity University of New York, School of Public HealthRan2024 to 2024Enrolled1,419ConditionsMisinformation, Vaccine Hesitancy, Anxiety, DepressionArmsAttitudinal inoculation, Cognitive-behavioral therapy-informed intervention, Conventional public health messaging
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Exploring COVID-19 Vaccine Decision Making: Insights from 'One-Shot Wonders' and 'Booster Enthusiasts'.International journal of environmental research and public health · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

McKaylee M RobertsonCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.ORCID 0000-0002-8426-6572
Sarah Gorrell KulkarniCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Madhura RaneCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Shivani KochharCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Amanda BerryCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Mindy ChangCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Chloe MirzayiCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.ORCID 0000-0002-9817-2868
William YouCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Andrew MarokoCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Rebecca ZimbaCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Drew WestmorelandCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Christian GrovCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Angela Marie ParcesepeCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Levi WaldronCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA.
Denis NashCity University of New York (CUNY) Institute for Implementation Science in Population Health, New York, New York, USA denis.nash@sph.cuny.edu.ORCID 0000-0002-3280-5386
CHASING COVID Cohort Study Team

Funding

Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Following a U.S. National Cohort of Vulnerable Men to Improve HIV Prevention and CareUH3AI133675 · NIAID · GRADUATE SCHOOL OF PUBLIC HEALTH AND HEALTH POLICY · PI GROV, CHRISTIAN · 2019 to 2021
$6.9M
NIAID NIH HHS UH3 AI133675NICHD NIH HHS P2C HD050924
6 · The paper itself

Abstract

purposeThe Communities, Households and SARS-CoV-2 Epidemiology (CHASING) COVID Cohort Study is a community-based prospective cohort study launched during the upswing of the USA COVID-19 epidemic. The objectives of the cohort study are to: (1) estimate and evaluate determinants of the incidence of SARS-CoV-2 infection, disease and deaths; (2) assess the impact of the pandemic on psychosocial and economic outcomes and (3) assess the uptake of pandemic mitigation strategies.

participantsWe began enrolling participants from 28 March 2020 using internet-based strategies. Adults≥18 years residing anywhere in the USA or US territories were eligible. 6740 people are enrolled in the cohort, including participants from all 50 US states, the District of Columbia, Puerto Rico and Guam. Participants are contacted regularly to complete study assessments, including interviews and dried blood spot specimen collection for serologic testing. FINDINGS TO DATE: Participants are geographically and sociodemographically diverse and include essential workers (19%). 84.2% remain engaged in cohort follow-up activities after enrolment. Data have been used to assess SARS-CoV-2 cumulative incidence, seroincidence and related risk factors at different phases of the US pandemic; the role of household crowding and the presence of children in the household as potential risk factors for severe COVID-19 early in the US pandemic; to describe the prevalence of anxiety symptoms and its relationship to COVID-19 outcomes and other potential stressors; to identify preferences for SARS-CoV-2 diagnostic testing when community transmission is on the rise via a discrete choice experiment and to assess vaccine hesitancy over time and its relationship to vaccine uptake. FUTURE PLANS: The CHASING COVID Cohort Study has outlined a research agenda that involves ongoing monitoring of the incidence and determinants of SARS-CoV-2 outcomes, mental health outcomes and economic outcomes. Additional priorities include assessing the incidence, prevalence and correlates of long-haul COVID-19.

Indexed as

COVID-19SARS-CoV-2AdultChildCohort StudiesCrowdingFamily CharacteristicsHumansPandemicsPost-Acute COVID-19 SyndromeProspective StudiesUnited Statesepidemiologyinfectious diseasesmental healthpublic health

Identifiers

PMID34548354
PMCPMC8458000

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.